Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Gingival depigmentation by conservative injectable vitamin C in comparison with scalpel surgery: a randomized controlled split-mouth clinical trial.

  • 2025-09-30
  • BMC research notes 18(1)
    • Manal M Al-Hajri
    • Abdulaziz M Tawfik
    • Redhwan Saleh Al-Gabri
    • Sadam Ahmed Elayah
    • Ahmed Yaseen Alqutaibi

Study Design

Type
Randomized Controlled Trial (RCT)
Population
20 healthy patients aged 19-36
Methods
Randomized split-mouth design, vitamin C injections (group 1) on one side and scalpel surgery (group 2) on the other side of the maxilla
Duration
6 months

Background

Gingival pigmentation (GP) is a common aesthetic concern in dentistry. While GP is not harmful, it can cause psychological distress. This study aimed to evaluate the efficacy of vitamin C injection for managing GP compared to the standard scalpel surgery.

Methods

The study involved 20 healthy patients aged 19-36. A randomized split-mouth design was used, with vitamin C injections (group 1) on one side and scalpel surgery (group 2) on the other side of the maxilla. Clinical evaluations of gingival depigmentation were conducted preoperatively and at first, second, three weeks and six months postoperatively, using the Gingival Pigmentation Index (GPI), Melanin Pigmentation Index (MPI), Dummett Oral Pigmentation Index (DOPI) and Color Intensity Analysis using ImageJ. Pain and patient satisfaction were measured with a visual analogue scale (VAS) after treatment.

Results

The GPI, MPI, and DOPI showed no significant differences in pigmentation between the groups at baseline and after six months (P = 1.0 and 0.80 for GPI; P = 1.00 and 0.54 for MPI; P = 1.00 and 0.59 for DOPI). However, after three weeks, greater depigmentation was noted on the surgical side. The vitamin C group reported lower pain and itching levels (itch: P = 0.02; pain: P = 0.00).

Trial registration

This randomized controlled trial was retrospectively registered in the Thai Clinical Trial Registry at 05-7-2024 ( www.thaiclinicaltrials.org ), and its registration number is TCTR20240715003.

Research Insights

  • The GPI, MPI, and DOPI showed no significant differences in pigmentation between the groups at baseline and after six months (P = 1.0 and 0.80 for GPI; P = 1.00 and 0.54 for MPI; P = 1.00 and 0.59 for DOPI).

    Effect
    Neutral
    Effect size
    Small
  • The GPI, MPI, and DOPI showed no significant differences in pigmentation between the groups at baseline and after six months (P = 1.0 and 0.80 for GPI)

    Effect
    Neutral
    Effect size
    Small
  • The vitamin C group reported lower pain and itching levels (itch: P = 0.02)

    Effect
    Beneficial
    Effect size
    Small
  • The GPI, MPI, and DOPI showed no significant differences in pigmentation between the groups at baseline and after six months (P = 1.00 and 0.54 for MPI)

    Effect
    Neutral
    Effect size
    Small
  • The GPI, MPI, and DOPI showed no significant differences in pigmentation between the groups at baseline and after six months (P = 1.00 and 0.59 for DOPI)

    Effect
    Neutral
    Effect size
    Small
  • The vitamin C group reported lower pain and itching levels (pain: P = 0.00)

    Effect
    Beneficial
    Effect size
    Small

Adverse Events Reported

  • Vitamin Citching

    The vitamin C group reported lower pain and itching levels (itch: P = 0.02; pain: P = 0.00).

    Finding
    No significant difference
    Magnitude
    itch: P = 0.02
    Significant
    Yes
  • Vitamin Cpain

    The vitamin C group reported lower pain and itching levels (itch: P = 0.02; pain: P = 0.00).

    Finding
    No significant difference
    Magnitude
    pain: P = 0.00
    Significant
    Yes
Back to top